Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Shank

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|October 1, 1990
Pyrroloisoquinoline antidepressants. 3. A focus on serotoninB E Maryanoff, J L Vaught, R P Shank, et al.
The Journal of Biological Chemistry|February 22, 2000
beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathologyH Y Wang, D H Lee, M R D'Andrea, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1988
McN-5652: a highly potent inhibitor of serotonin uptakeR P Shank, J L Vaught, K A Pelley, et al.
European Journal of Pharmacology|November 1, 1988
Block of conditioned avoidance responding in the rat by substituted phenylpiperazinesG E Martin, R J Elgin, J M Kesslick, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1993
Complementary and synergistic antinociceptive interaction between the enantiomers of tramadolR B Raffa, E Friderichs, W Reimann, et al.
Journal of Medicinal Chemistry|August 1, 1984
Pyrroloisoquinoline antidepressants. Potent, enantioselective inhibition of tetrabenazine-induced ptosis and neuronal uptake of norepinephrine, dopamine, and serotoninB E Maryanoff, D F McComsey, M J Castanzo, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1987
Preclinical evaluation of McN-5707 as a potential antidepressantR P Shank, J F Gardocki, C R Schneider, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 1999
Potential anxiolytic agents. 3. Novel A-ring modified pyrido[1,2-a]benzimidazolesB E Maryanoff, S O Nortey, J J McNally, et al.
Journal of Medicinal Chemistry|May 9, 1998
Structure-activity studies on anticonvulsant sugar sulfamates related to topiramate. Enhanced potency with cyclic sulfate derivativesB E Maryanoff, M J Costanzo, S O Nortey, et al.
Journal of Medicinal Chemistry|August 1, 1987
Pyrroloisoquinoline antidepressants. 2. In-depth exploration of structure-activity relationshipsB E Maryanoff, D F McComsey, J F Gardocki, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|October 1, 1990
Pyrroloisoquinoline antidepressants. 3. A focus on serotoninB E Maryanoff, J L Vaught, R P Shank, et al.
The Journal of Biological Chemistry|February 22, 2000
beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathologyH Y Wang, D H Lee, M R D'Andrea, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1988
McN-5652: a highly potent inhibitor of serotonin uptakeR P Shank, J L Vaught, K A Pelley, et al.
European Journal of Pharmacology|November 1, 1988
Block of conditioned avoidance responding in the rat by substituted phenylpiperazinesG E Martin, R J Elgin, J M Kesslick, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1993
Complementary and synergistic antinociceptive interaction between the enantiomers of tramadolR B Raffa, E Friderichs, W Reimann, et al.
Journal of Medicinal Chemistry|August 1, 1984
Pyrroloisoquinoline antidepressants. Potent, enantioselective inhibition of tetrabenazine-induced ptosis and neuronal uptake of norepinephrine, dopamine, and serotoninB E Maryanoff, D F McComsey, M J Castanzo, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1987
Preclinical evaluation of McN-5707 as a potential antidepressantR P Shank, J F Gardocki, C R Schneider, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 1999
Potential anxiolytic agents. 3. Novel A-ring modified pyrido[1,2-a]benzimidazolesB E Maryanoff, S O Nortey, J J McNally, et al.
Journal of Medicinal Chemistry|May 9, 1998
Structure-activity studies on anticonvulsant sugar sulfamates related to topiramate. Enhanced potency with cyclic sulfate derivativesB E Maryanoff, M J Costanzo, S O Nortey, et al.
Journal of Medicinal Chemistry|August 1, 1987
Pyrroloisoquinoline antidepressants. 2. In-depth exploration of structure-activity relationshipsB E Maryanoff, D F McComsey, J F Gardocki, et al.
Pageof 8